ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Lung Cancer

Breast Cancer trials near Kansas City, KS, USA:

Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer (MAINTAIN)

This is a randomized trial for patients with metastatic hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative breast...

Active, not recruiting
Metastatic Breast Cancer
Breast Carcinoma
Drug: LEE-011
Drug: Fulvestrant

Phase 2

Melissa K Accordino

Westwood, Kansas, United States and 12 other locations

Choice (TPC) in advanced metastatic or locally recurrent breast cancer (aMBC) patients with no approved alternative therapies avail...

Enrolling
Breast Cancer
Breast Neoplasm
Drug: Cyclophosphamide
Drug: Retifanlimab

Phase 3

BriaCell Therapeutics

Kansas City, Kansas, United States and 3 other locations

Study combination use of cisplatin plus romidepsin and nivolumab in metastatic triple negative breast cancer (TNBC) or BRCA mutatio ...

Active, not recruiting
Breast Cancer
Triple-Negative Breast Cancer
Drug: Cisplatin
Drug: Romidepsin

Phase 1, Phase 2

Priyanka Sharma

Kansas City, Kansas, United States and 6 other locations

This study will be conducted in patients with metastatic breast cancer who have specific Fibroblast Growth Factor Receptor gene abn...

Active, not recruiting
Metastatic Breast Cancer
FGFR 1 High Amplification
Drug: Futibatinib
Drug: Futibatinib plus Fulvestrant

Phase 2

Taiho Pharma
Taiho Pharma

Kansas City, Missouri, United States and 36 other locations

The standard treatment for women with stage I, II, and III triple-negative breast cancer (TNBC) includes chemotherapy and surgery, ...

Active, not recruiting
Triple-negative Breast Cancer
Drug: Carboplatin
Drug: Pegfilgrastim

Phase 2

University of Kansas
University of Kansas

Kansas City, Kansas, United States and 8 other locations

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo

Kansas City, Missouri, United States and 226 other locations

participants with metastatic or locally advanced Hormone Receptor (HR) positive and Human Epidermal Growth Factor Receptor (HER)2-negative breast...

Enrolling
Breast Cancer
Locally Advanced Breast Cancer
Drug: Samuraciclib
Drug: Fulvestrant

Phase 2

Carrick Therapeutics

Kansas City, Missouri, United States and 19 other locations

together. A side effect is anything a drug does besides treating cancer.Participants in this trial have HER2-positive (HER2+) breast...

Active, not recruiting
HER2 Positive Breast Cancer
Drug: trastuzumab deruxtecan
Drug: tucatinib

Phase 2

Seagen
Seagen

Kansas City, Missouri, United States and 32 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Kansas City, Missouri, United States and 50 other locations

The purpose of this study will be to evaluate, in a multi-center setting, the ability of radiofrequency ablation (RFA) of breast cancer...

Active, not recruiting
Breast Cancer
Device: Radiofrequency Ablation
University of Arkansas
University of Arkansas

Westwood, Kansas, United States and 5 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems